{
    "organizations": [],
    "uuid": "1fee75cf2b16eb485542ec006ebbf5c522cf341b",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-northeast-pharmaceutical-group-see/brief-northeast-pharmaceutical-group-sees-fy-2018-q1-net-profit-up-341-pct-to-387-pct-idUSL3N1RT3HO",
    "ord_in_thread": 0,
    "title": "BRIEF-Northeast Pharmaceutical Group sees FY 2018 Q1 net profit up 341 pct to 387 pct",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 16(Reuters) - Northeast Pharmaceutical Group Co Ltd\n* Sees FY 2018 Q1 net profit to increase by 341 percent to 387 percent, or to be 48 million yuan to 53 million yuan\n* Says FY 2017 Q1 net profit was 10.9 million yuan\n* Says rising price of vitamin C and increased sales of preparation products are the main reasons for the forecast\nSource text in Chinese: goo.gl/Kks91k\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-04-16T16:33:00.000+03:00",
    "crawled": "2018-04-17T12:32:43.002+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "northeast",
        "pharmaceutical",
        "group",
        "co",
        "ltd",
        "see",
        "fy",
        "q1",
        "net",
        "profit",
        "increase",
        "percent",
        "percent",
        "million",
        "yuan",
        "million",
        "yuan",
        "say",
        "fy",
        "q1",
        "net",
        "profit",
        "million",
        "yuan",
        "say",
        "rising",
        "price",
        "vitamin",
        "c",
        "increased",
        "sale",
        "preparation",
        "product",
        "main",
        "reason",
        "forecast",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}